Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vyzulta


Contraindicated
No available information

To avoid
Unknown effect on breastfed infants
Vyzulta :
Type Medicine Authorised
Originator B
Agent Spephal
Distributor Spephal
Laboratory Bausch & Lomb
Responsible Party Bausch and Lomb Incorporated
Origin U.S.A.
Manufacturer Bausch & Lomb Inc
Origin U.S.A.
ATC S01EE06

Your comment will appear shortly after approval

Vyzulta :

Revision Date : 12/05/2016


Effect Frequency
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Bronchospasm Not known
Cataract Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Not known
Dyspnoea (dyspnea) Not known
Epistaxis (Nasal bleeding) Very Common
Glaucoma Not known
Headache Common
Hypersensitivity Not known
Intraocular pressure increased Not known
Nasal burning Common
Nasal irritation Common
Nasal septum perforation Not known
Nasal ulcer Common
Parosmia Not known
Pharyngitis Common
Throat irritation Common
Upper respiratory tract infection Common

Different Units By MoH Code

Revision Date : 01/05/2019

Vyzulta  MoH 10832 :
Form Eye drops, solution
Packaging Bottle (PELD) (low density polyethylene)
Package Size Bottle of 2.5ml
Strength 0.024%
Public Price 1948571.62 L.L.
Stratum B
NSSF ✘
Quarantine ✘
Reg. Number 141920/1
Submission date 01/10/2020
Registration Year 27/10/2021


Price Comparison

● Country: Lebanon
● Form: Eye drops, solution
● Package Size: Bottle of 2.5ml
● Pack size unit used: 50
● Cost/Unit: 38971.43 LBP ( 38,971.43 LBP )
● Pricing Date: 12/12/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Open-angle glaucoma : (Adults)
● Cost/Unit: 38971.43 LBP ( 38,971.43 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info